Home›Search›Psychopharmakotherapie

Psychopharmakotherapie

Wissenschaftliche Verlagsgesellschaft mbH · Germany

ISSN0944-6877

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.117

H-Indexi

SNIPi

0.032

Total Worksi

Total Citationsi

2yr Mean Citednessi

0.02

Open Impact Factor alternative

Aims & Scope✦ Compiled from public sources

Psychopharmakotherapie is a German-language journal focused on the pharmacotherapy of psychiatric and neurologic diseases. It covers aspects such as pharmacology, clinical research evaluation, post-marketing surveillance, drug risks, pharmacoeconomics, and practical experiences.

AI-compiled from public web sources · verify on the publisher page

General Information

Country / RegionGermany

Primary Language—

1st Year Published—

Annual Volume~ 13 articles / year

StatusActive

Total Publications68

Publisher OrgMediengruppe Deutscher Apotheker Verlag

Submission Info

Publishing ModelSubscription

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/11 · 36%

✅

Do you know the journal / publisher?

Wissenschaftliche Verlagsgesellschaft mbH

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

0944-6877

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

2001

2003

2006

2008

2010

2020

2025

2026

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Pharmacology (medical)Q4

Psychiatry and Mental HealthQ4

Subject Classification

Scopus Categories

Pharmacology (medical)Psychiatry and Mental Health

Research Topics (OpenAlex)

Schizophrenia research and treatmentTreatment of Major DepressionPsychiatric care and mental health servicesBiomedical and Chemical ResearchSubstance Abuse Treatment and OutcomesChild and Adolescent Psychosocial and Emotional DevelopmentEpilepsy research and treatmentDiabetes Treatment and ManagementMigraine and Headache StudiesForensic Toxicology and Drug Analysis

Frequently asked questions about Psychopharmakotherapie

Is Psychopharmakotherapie a predatory journal?

PubScope has no integrity flags on record for Psychopharmakotherapie: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Psychopharmakotherapie?

Psychopharmakotherapie is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.117.

Is Psychopharmakotherapie indexed in Scopus and Web of Science?

Psychopharmakotherapie is indexed in Scopus.